Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1993-2-2
|
pubmed:abstractText |
We have suggested a growth stimulatory role of lymphoma cells in culture by interleukin 6. To test the hypothesis that IL-6 may have a role in vivo, the plasma of lymphoma patients was assayed for the presence of IL-6 bioactivity. A significantly greater proportion of lymphoma patients had elevated IL-6 levels (23 of 40) compared to controls (3 of 35). In follow-up, eight of 15 patients with previously elevated levels returned with decreased or undetectable levels of IL-6 post radio- or chemotherapy. This response was seen primarily in those with intermediate or high grade lymphomas. In contrast no change in IL-6 levels was seen in patients with low grade lymphoma despite measurable reductions in tumor size in both groups.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1472922-Biological Assay,
pubmed-meshheading:1472922-Cell Line,
pubmed-meshheading:1472922-Follow-Up Studies,
pubmed-meshheading:1472922-Humans,
pubmed-meshheading:1472922-Interleukin-6,
pubmed-meshheading:1472922-Lymphoma, Non-Hodgkin,
pubmed-meshheading:1472922-Neoplasm Staging,
pubmed-meshheading:1472922-Reference Values
|
pubmed:year |
1992
|
pubmed:articleTitle |
Interleukin-6 levels in the plasma of patients with lymphoma.
|
pubmed:affiliation |
Department of Medicine and Bioresearch, Ontario Cancer Institute, Toronto, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|